Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009

JA Gallego, J Bonetti, J Zhang, JM Kane… - Schizophrenia research, 2012 - Elsevier
OBJECTIVE: To assess the prevalence and correlates of antipsychotic polypharmacy (APP)
across decades and regions. METHODS: Electronic PubMed/Google Scholar search for …

Safety and tolerability of antipsychotic polypharmacy

JA Gallego, J Nielsen, M De Hert, JM Kane… - Expert opinion on …, 2012 - Taylor & Francis
Introduction: Antipsychotic polypharmacy (APP), the concomitant use of≥ 2 antipsychotics,
is common in clinical practice. Prior reviews have focused on the efficacy of APP, but no …

Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology

TRE Barnes… - Journal of …, 2011 - journals.sagepub.com
These guidelines from the British Association for Psychopharmacology address the scope
and targets of pharmacological treatment for schizophrenia. A consensus meeting, involving …

[图书][B] The Maudsley prescribing guidelines

D Taylor, C Paton - 2009 - taylorfrancis.com
One of the most widely used guides to prescribing psychiatric medications, the Tenth Edition
of Maudsley Prescribing Guidelines returns with fully updated content and new sections on …

Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice

CU Correll, JA Gallego - Psychiatric Clinics, 2012 - psych.theclinics.com
Methods We conducted an electronic search in PubMed for correlates of APP (last update
September 09, 2011), using the following key words:“(antipsychotic OR antipsychotics OR …

Switching to antipsychotic monotherapy vs. staying on antipsychotic polypharmacy in schizophrenia: A systematic review and meta-analysis

K Matsui, T Tokumasu, Y Takekita, K Inada… - Schizophrenia …, 2019 - Elsevier
Background While recent meta-analyses have reported the superiority of antipsychotic
polypharmacy (APP) over antipsychotic monotherapy (APM) in schizophrenia, switching to …

The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial

C Tek, LB Palmese, AD Krystal, VH Srihari… - Schizophrenia …, 2014 - Elsevier
Background Insomnia is frequent in schizophrenia and may contribute to cognitive
impairment as well as overuse of weight inducing sedative antipsychotics. We investigated …

Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset

F Berna, D Misdrahi, L Boyer, B Aouizerate… - Schizophrenia …, 2015 - Elsevier
The main objective of this study was to determine the prevalence of akathisia in a community-
dwelling sample of patients with schizophrenia, and to determine the effects of treatments …

The prevalence and factors associated with antipsychotic polypharmacy in a forensic psychiatric sample

C Farrell, J Brink - Frontiers in psychiatry, 2020 - frontiersin.org
Despite clinical guidelines limiting the use of multiple concomitant antipsychotics to the most
exceptional and treatment resistant cases, the prevalence of antipsychotic polypharmacy …

Drug treatment patterns in bipolar disorder: analysis of long-term self-reported data

M Bauer, T Glenn, M Alda, K Sagduyu, W Marsh… - International journal of …, 2013 - Springer
Background The objective of this study is to investigate drug treatment patterns in bipolar
disorder using daily data from patients who received treatment as usual. Methods Patients …